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ABSTRACT
APE1/Ref-1 is thought to be a multifunctional pro-
tein involved in reduction–oxidation (redox) regula-
tion and base excision DNA repair, and is required
for early embryonic development in mice. APE1/
Ref-1 has redox activity and AP endonuclease activ-
ity, and is able to enhance DNA-binding activity
of several transcription factors, including NF-iB,
AP-1 and p53, through reduction of their critical
cysteine residues. However, it remains elusive
exactly how APE1/Ref-1 carries out its essential
functions in vivo. Here, we show that APE1/Ref-1
not only reduces target transcription factors directly
but also facilitates their reduction by other reducing
molecules such as glutathione or thioredoxin. The
new activity of APE1/Ref-1, termed redox chaperone
activity, is exerted at concentration significantly
lower than that required for its redox activity and
is neither dependent on its redox activity nor on its
AP endonuclease activity. We also show evidence
that redox chaperone activity of APE1/Ref-1 is criti-
cal to NF-iB-mediated gene expression in human
cells and is mediated through its physical associa-
tion with target transcription factors. Thus, APE1/
Ref-1 may play multiple roles in an antioxidative
stress response pathway through its different bio-
chemical activities. These findings also provide new
insight into the mechanism of intracellular redox
regulation.
INTRODUCTION
The reduction–oxidation (redox) states of cysteine resid-
ues, which can change reversibly within cells, often greatly
inﬂuence the various properties of proteins, such as pro-
tein stability, chaperone activity, enzymatic activity and
protein structure (1–5). It has been shown that the redox
states of cysteine residues of several transcription factors,
most of which are located in the DNA-binding domains,
aﬀect their DNA-binding activity through redox mecha-
nisms (6–18). For example, a cysteine residue in the highly
conserved Rel homology DNA-binding domain (RHD) of
NF-kB, such as Cys-62 of p50, needs to be in a reduced
state for eﬃcient DNA binding (19–22). We have shown in
a previous report that Cys-62 of p50 is highly oxidized in
the cytoplasm, and that after stimulation, it is converted
to the reduced form in the nucleus to gain DNA-binding
activity (23). Thus, redox regulation is an important mode
of regulation for several transcription factors.
Glutathione (GSH) and thioredoxin (Trx) are two
major intracellular redox systems. GSH is the most abun-
dant tripeptide thiol in mammalian cells that is present at
millimolar concentrations and plays a pivotal role in the
maintenance of cellular reducing environment and defense
against oxidative stress (24–29). On the other hand, Trx is
a highly conserved disulﬁde reductase that catalyzes
reduction through the NADPH-dependent thioredoxin
reductase (TrxR) system. The Trx system plays an impor-
tant role in the redox regulation of multiple intracellular
processes, including DNA synthesis, cell growth and resis-
tance to oxidative stress and apoptosis (30).
Furthermore, APE1/Ref-1 (for AP endonuclease 1/
redox factor 1) is known to contribute to redox regulation.
APE1/Ref-1 was originally identiﬁed as a DNA repair
enzyme with apurinic/apyrimidinic (AP) endonuclease
activity and was shown to be important for the base exci-
sion repair pathway (31–33). Subsequently, it was reported
that APE1/Ref-1 reduces a redox-sensitive cysteine residue
of the transcription factor AP-1 and thereby facilitates its
DNA-binding and transcriptional activities (6,7). APE1/
Ref-1 is now known to enhance DNA-binding activity of
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Egr-1 (8), HIF-1a (9–11), HLF (9), Pax-5, Pax-8 (12–15)
and p53 (16,17), by regulating their redox states. Thus,
APE1/Ref-1 is thought to be a multifunctional protein
involved in both base excision DNA repair and redox reg-
ulation of transcription factors.
Despite accumulating evidence for the role of APE1/
Ref-1 in redox regulation, the underlying mechanism is
poorly understood. Although initial studies suggested
that Cys-65 of human APE1/Ref-1 (Cys-64 of mouse
APE1/Ref-1) is critical for redox regulation of AP-1
(35), subsequent analyses showed that this cysteine residue
is not involved in redox regulation (36,37). Thus, we
initiated biochemical analyses to elucidate the mechanism
of APE1/Ref-1 redox regulation, with a focus on possible
interplay among APE1/Ref-1 and other redox systems
such as GSH and Trx. Here, we report an unexpected
ﬁnding that APE1/Ref-1 not only reduces transcription
factors such as NF-kB or AP-1 directly, but also assists
their reduction by other reducing molecules such as GSH
or Trx independently of the cysteine residues of APE1/
Ref-1. Using reporter gene assays, we also show that
APE1/Ref-1 augments NF-kB-mediated transcription
independently of its cysteine residues. These results sug-
gest that APE1/Ref-1 acts as a ‘redox chaperone’ that
facilitates the reduction of redox-sensitive transcription
factors by other reducing molecules.
MATERIALS AND METHODS
Preparation ofbacterial recombinant proteins
The pET-14b (Novagen, Madison, WI, USA)-based
expression plasmids of full-length human APE1/Ref-1,
p50, p50 C62S, p65 and Trx, and pGEX-APE1/Ref-1
have been described previously (23,34). For the APE1/
Ref-1C/S mutant, site-directed mutagenesis was carried
out by the PCR-based overlap extension technique, and
the resulting cDNA fragment was cloned into pET-14b
or pGEX-6T-1 (GE Healthcare, Buckinghamshire, UK).
The cDNAs encoding p52 and c-Rel were obtained by
RT–PCR using human total RNA isolated from Jurkat
cells and were introduced, respectively, into pET-14b.
Expression vectors of p65 RHD, p52 RHD and c-Rel
RHD were prepared by inserting the corresponding DNA
fragments into the NdeI–BamHI sites of pET-14b. To con-
struct expression plasmids for the bZIP domains of c-Jun
and c-Fos, the DNA fragments encoding amino acids
222–331 of human c-Jun and 118–221 of human c-Fos
were ampliﬁed by PCR and cloned into pET-14b. Bacterial
expression and puriﬁcation of histidine-tagged proteins
were performed as described previously (23).
Glutathione S-transferase pull-down assays
To prepare
35S-labeled proteins, pET-14b p50, p65 RHD,
p52 RHD, c-Rel RHD, c-Jun bZIP and c-Fos bZIP were
transcribed and translated using TNT T7 quick coupled
transcription/translation system (Promega, Madison, WI,
USA). Escherichia coli strain BL21 (DE3) lysates
containing 1mg of glutathione S-transferase (GST),
GST-APE1/Ref-1 WT or GST APE1/Ref-1C/S were
incubated with 30ml of glutathione Sepharose 4B resin
(GE Healthcare) for 1h at 48C. After washing three times
with 300ml of 0.1HgKEN (20mM HEPES pH 7.9, 100mM
KCl, 0.2mM EDTA, 0.1% NP-40, and 10% glycerol), the
resin was incubated with 2mlo f
35S-labeled proteins in
300ml of 0.1HgKEN for 1h at 48C. After the resin was
washed with300ml of0.1HgKEN sixtimes, boundproteins
were eluted with 30 ml of Laemmli buﬀer, resolved by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE), and visualized by Coomassie blue staining
and autoradiography.
Electrophoretic mobility shiftassays
Immediately prior to use, puriﬁed recombinant transcrip-
tion factors were oxidized with diamide, and unreacted
diamide was removed from protein samples by aﬃnity pur-
iﬁcation, as described (23). Recombinant proteins were
then incubated in 10ml of 0.1HgKEN with 1mg of poly
(dI-dC) (dI-dC) at 378C for 30min. Where indicated,
reduced L-glutathione (Sigma-Aldrich, St. Louis, MO,
USA) or TrxR from rat liver (Sigma) and NADPH
(Sigma) were included in the reactions. Where indicated,
anti-APE1/Ref-1 or anti-Trx was also included, and the
reactions were incubated on ice for an additional 30min.
Then, 1pmol of
32P-labeled probe was added, and the reac-
tions were further incubated on ice for 20min. The reaction
mixture was then subjected to native 4% polyacrylamide
gels in 0.5 Tris borate–EDTA buﬀer at 48C. The oligo-
nucleotide probe containing an NF-kB- or AP-1 site was
prepared by annealing the following oligonucleotides:
sense, 50-AGTTGAGGGGACTTTCCC-30 and antisense,
50-GCCTGGGAAAGTCCCTC-30 for NF-kB; sense, 50-G
AGCCGCAAGTGACTCAGCGCGGGGCGTGTG-30
and antisense, 50-GGCGTTCACTGAGTCGCGCCCCG
CACACGTCC-30 for AP-1. In Figure 6D, nuclear extracts
were prepared from transfected 293T cells as described
before (38), and subjected to electrophoretic mobility
shift assay (EMSA).
Fluorescence assays
Oxidized transcription factors were incubated in
0.1HgKEN for various times at 378C in the presence or
absence of reduced L-glutathione or TrxR from rat liver
and NADPH. Then, to modify reduced cysteine residues,
reaction mixtures were incubated with 2mM ﬂuorescence-
5-maleimide (F5M, Molecular Probes, Eugene, OR,
USA) on ice for 5min. Reactions were terminated by addi-
tion of L-Cys to a ﬁnal concentration of 20mM, and
unreacted F5M was removed by acetone precipitation.
Precipitated proteins were resuspended in Laemmli
buﬀer, separated by SDS–PAGE, and analyzed with a
ﬂuorescence scanner as described previously (23).
AP endonuclease assays
AP endonuclease activity of APE1/Ref-1 was examined by
the conversion of supercoiled, depurinated pBluescript II
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performed as described previously (7). Depurinated DNA
(200ng) in a 20ml reaction volume was incubated with
APE1/Ref-1at the indicated concentrations for 15min at
378C in 10mM Tris–HCl pH 8.0, 5mM MgCl2,1 m M
EDTA and 0.01% NP-40. Reaction products were then
electrophoresed on a 0.8% agarose gel and visualized by
ethidium bromide staining.
Knockdown using siRNA
The siRNA duplex for APE1/Ref-1 was prepared by
annealing two oligonucleotides; sense, 50-GUCUGGUAC
GACUGGAGUACC-30 andantisense,50-UACUCCAGU
CGUACCAGACCU-30. The siRNA duplex for green ﬂu-
orescent protein (GFP) was purchased from Dharmacon
(Lafayette,CO,USA).293TcellsweregrowninDulbecco’s
modiﬁedEagle’smedium(Invitrogen,Carlsbad,CA,USA)
supplemented with 10% fetal bovine serum, 100mg/ml
penicillin and 100mg/ml streptomycin. For knockdown of
endogenous APE1/Ref-1, 1day before transfection, 293T
cells were seeded on 6-well plates, and 125 pmol of siRNA
was transfected using Lipofectamine 2000 reagent
(Invitrogen). After 24h, transfected cells were seeded at
an appropriate density and further grown for 1–4 days.
The cells were then lyzed with RIPA buﬀer (10mM Tris–
HCl pH 8.0, 140mM NaCl, 0.1% SDS, 1% Triton-X-100,
0.1% sodium deoxycholate, 1mM EDTA and 0.5mM
EGTA), incubated on ice for 30min and centrifuged. The
supernatants were mixed with Laemmli buﬀer, subjected to
SDS–PAGE and immunoblotted using anti-APE1/Ref-1
and anti-actin (MAB1501, Chemicon, Temecula, CA,
USA)antibodies.Anti-APE1/Ref-1antibodywasprepared
from rabbit using puriﬁed bacterial recombinant full-
length APE1/Ref-1 as an antigen.
Reporter gene assays
The pHygEF2-ﬂag-Ref-1 WT anti-siRNA and pHygEF2-
ﬂag-Ref-1C/S anti-siRNA are expression plasmids for
Flag-tagged, siRNA-resistant APE1/Ref-1. To confer
resistance to siRNA, two synonymous mutations were
introduced by the overlap extension technique into the
siRNA-targeted sequence of APE1/Ref-1 as follows (sub-
stituted nucleotides underlined): 50-GTCTGGTACGACT
GGAGTACC-30. For reporter gene assays, 293T cells were
seeded on 6-well plates 1day before transfection and trans-
fected with 125 pmol of siRNA, 0.125mg of pNHkBHL
containing four NF-kB-binding sites and the ﬁreﬂy lucifer-
ase gene (39), and 0.05mg of pEF-Rluc containing the con-
trol Renilla luciferase gene (40) using Lipofectamine 2000
reagent. Twenty-four hours later, one of the siRNA-resis-
tant APE1/Ref-1 expression plasmids was transfected
again into the cells. Six hours after the second transfection,
the cells were reseeded on new 24-well plates at a 1:8 dilu-
tion. Twenty-four hours after the second transfection, the
cells were treated with 10ng/ml TNF-a (Pepro Tech,
Rocky Hill, NJ, USA) and cultured for another 24h.
The cell extracts were prepared, and ﬁreﬂy and Renilla luci-
ferase activities were measured using Dual-Luciferase
Reporter Assay System (Promega) and Lumat LB9501
(Berthold Technologies, Bad Wildbad, Germany).
RESULTS
APE1/Ref-1 has two distincteffects onDNA-binding
activity ofNF-iB p50
Previously, we and others have shown that Cys-62 of
NF-kB p50, the key cysteine residue involved in its
DNA binding is redox-regulated by APE1/Ref-1 and
Trx (20,22,23,34). In this study, we investigated potential
interplay among diﬀerent redox systems present in cells
using p50 reduction as a model. As a measure of the
redox states of Cys-62, DNA-binding activity of p50 was
measured by EMSA using recombinant p50 that was oxi-
dized with diamide prior to use. Whereas oxidized p50
showed little DNA binding without additional factors, it
generated a shifted band in the presence of 1mM DTT
(Figure 1A). GSH and Trx increased p50 DNA binding
in a concentration-dependent manner. As reported pre-
viously (20,23,34), APE1/Ref-1 also increased p50 DNA
binding at relatively high concentrations, thatis, atconcen-
trations >50-fold higher than that of p50. Remarkably,
APE1/Ref-1, when used together with a limiting con-
centration of GSH or Trx, strongly increased p50 DNA
binding at concentrations as low as 0.5mM. Similar
observation was previously obtained with APE1/Ref-1
and Trx (20).
We speculated that in the presence of APE1/Ref-1 and
GSH or Trx, APE1/Ref-1 is mainly involved in p50 reduc-
tion, and that GSH or Trx may facilitate p50 DNA binding
by converting oxidized APE1/Ref-1 to a reduced state. We
therefore sought to determine cysteine residues of APE1/
Ref-1 critical to p50 reduction. To our surprise, APE1/Ref-
1C/S, in which all the seven cysteine residues were substi-
tuted to serine, increased p50 DNA binding as eﬃciently as
APE1/Ref-1 WT in the presence of GSH or Trx (Figure 1B
and C, and data not shown). Therefore, contrary to the
above proposition, redox activity of APE1/Ref-1 is not
involved in the activation of p50 DNA binding under
these conditions. On the other hand, in the absence of
GSH and Trx, APE1/Ref-1C/S had negligible eﬀect on
p50 DNA binding even at the highest concentration exam-
ined (Figure 1C), consistent with the idea that redox activ-
ity of APE1/Ref-1 is involved in theactivation of p50 DNA
binding in the absence of other reducing molecules. These
results revealed that APE1/Ref-1 has two distinct eﬀects on
p50 DNA binding. First, as reported previously, APE1/
Ref-1 activates p50 DNA binding directly in a Cys-depen-
dent manner, which requires high concentrations of
APE1/Ref-1. Second, in the presence of GSH or Trx,
APE1/Ref-1 also activates p50 DNA binding indirectly
in a Cys-independent manner at low concentrations of
APE1/Ref-1.
We previously showed that APE1/Ref-1 physically inter-
acts with p50 (34). Since APE1/Ref-1C/S stimulated p50
DNA binding as well as APE1/Ref-1 WT under certain
conditions, we assumed that APE1/Ref-1C/S may also
interact with p50. As expected, GST pull-down assays
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nottocontrolGST(Figure 1D),indicatingthatAPE1/Ref-
1 interacts with p50 independently of its cysteine residues.
APE1/Ref-1 promotes GSH- or Trx-mediated
reduction ofp50
We investigated the cysteine-independent function of
APE1/Ref-1 in more detail. The above ﬁndings may be
interpreted as follows: APE1/Ref-1 and GSH or Trx may
facilitate p50 DNA binding by a redox-independent
mechanism. Alternatively, APE1/Ref-1 may promote
GSH- or Trx-mediated reduction of p50. To discriminate
these possibilities, we carried out two lines of experiments.
First, we examined by EMSA whether the synergistic eﬀect
ofAPE1/Ref-1 andGSHor Trx is mediatedbyp50 Cys-62.
For this, p50 C62S, which mimics the reduced form of p50
and binds to DNA in a redox-independent manner (21,23),
was used. As shown in Figure 2A, APE1/Ref-1 WT or C/S
had negligible eﬀect on DNA binding by p50 C62S regard-
less of the presence of GSH or Trx, demonstrating that p50
Cys-62 is a target for the synergistic eﬀect of APE1/Ref-1
and GSH or Trx. Second, we analyzed the redox status of
p50 using a thiol-modifying ﬂuorescent reagent, F5M, as
described (23). Following redox reactions, free cysteine
residues of p50 were ﬂuorescently labeled and visualized
by SDS–PAGE and ﬂuorescence scanning. At the concen-
trations used here, APE1/Ref-1 WT or C/S had negligible
eﬀect on the redox status of p50 in the absence of GSH and
Trx, but in the presence of either GSH or Trx, APE1/Ref-1
WT and C/S similarly enhanced p50 reduction (Figure 2B
and D). On the other hand, p50 C62S was reduced only
weakly under the same conditions (Figure 2C). These
results indicate that independently of its cysteine residues,
Figure 1. APE1/Ref-1 has two distinct eﬀects on DNA-binding activity of NF-kB p50. (A) NF-kB p50 (0.05mM) was incubated with the indicated
concentrations of GSH, Trx and APE1/Ref-1 WT either individually or in combination for 30min, and then EMSA was performed with NF-kB
probe. When Trx was used, 13–16 nM TrxR and 0.2mM NADPH were also included in binding reactions. Where indicated, anti-APE1/Ref-1 or
anti-Trx was included in the reactions. Asterisk indicates the APE1/Ref-1-DNA complex. (B) Schematic structure of APE1/Ref-1 WT and C/S. (C)
EMSA were performed using APE1/Ref-1C/S as in (A). (D) Protein–protein interactions of APE1/Ref-1 with p50. GST pull-down assays were
performed as described in Materials and methods section.
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p50. We termed the ability of APE1/Ref-1 to facilitate
reduction of target transcription factors by other reducing
molecules as redox chaperone activity.
Effects of APE1/Ref-1 and GSHon other
transcription factors
We extended the study on redox chaperone activity to
other members of the Rel family, such as p52, p65 and
c-Rel. They have a redox-sensitive cysteine residue in their
respective DNA-binding domains (21). First, we examined
whether APE1/Ref-1 WT and C/S bind to these Rel family
members using GST pull-down assays. As shown in
Figure 3A, p52 and c-Rel, but not p65, bound to both
APE1/Ref-1 WT and C/S. Next, EMSA were performed
to investigate whether APE1/Ref-1 aﬀects their DNA-
binding activity. At a low concentration of APE1/Ref-1
and in the presence of GSH, APE1/Ref-1 WT and C/S
enhanced DNA-binding activity of p52 (Figure 3B) and
c-Rel (Figure 3C), but not of p65 (Figure 3D). These
results suggest that APE1/Ref-1 binds to and modulates
a subset of transcription factors through its redox chaper-
one activity with some speciﬁcity. Apparent correlation
between APE1/Ref-1 binding and redox chaperone activ-
ity suggests that selective binding to target transcription
factors by APE1/Ref-1 may be a prerequisite for its redox
chaperone activity.
We also examined a potential role of redox chaperone
activity in another redox-sensitive transcription factor,
AP-1. AP-1 is a heterodimer of c-Fos and c-Jun, whose
DNA-binding activity is known to be regulated by APE1/
Ref-1 (6,7). APE1/Ref-1 targets Cys-272 of c-Fos and
Cys-154 of c-Jun, conserved cysteine residues that are
located in their respective basic leucine zipper (bZIP)-
type DNA-binding domains (6). GST pull-down assays
showed that APE1/Ref-1 WT and C/S bind to the c-Jun
bZIP, but not to the c-Fos bZIP (Figure 4A). EMSA
showed that in the presence of GSH, APE1/Ref-1
enhanced DNA-binding activity of the c-Jun/c-Fos bZIP
heterodimer independently of the cysteine residues of
APE1/Ref-1 (Figure 4B). These results suggest that
DNA-binding activity of AP-1 is promoted not only by
redox activity of APE1/Ref-1, as noted before (6,7), but
also by its redox chaperone activity. This prompted us to
examine the redox states of c-Fos and c-Jun by ﬂuores-
cence assays. As expected, both the c-Jun bZIP and the
c-Fos bZIP were weakly reduced by GSH, and the reduc-
tion was promoted by APE1/Ref-1 WT or C/S
(Figure 4C). APE1/Ref-1 alone could not reduce the
c-Jun bZIP and the c-Fos bZIP appreciably at the con-
centration used here (Figure 4C). These results suggest
that APE1/Ref-1 binds to the c-Jun bZIP and thereby
enhances the reduction of both the c-Jun bZIP and the
c-Fos bZIP, leading to increased DNA binding by the
c-Jun/c-Fos bZIP heterodimer.
Redox activity, DNA-binding activity andAP
endonuclease activity ofAPE1/Ref-1 are dispensable
forits redox chaperoneactivity
Since APE1/Ref-1 is a multifunctional protein, we were
interested in whether redox chaperone activity of APE1/
Ref-1 is dependent on other activities it possesses.
The ability of APE1/Ref-1 to promote p50 DNA binding
in the absence of other reducing molecules (Figure 1A) has
Figure 2. APE1/Ref-1 promotes GSH- or Trx-mediated reduction of
p50. (A) The p50 Cys-62 is a target for the synergistic eﬀect of
APE1/Ref-1 and GSH or Trx. The p50 WT or C62S (0.05mM) was
incubated with the indicated concentrations of APE1/Ref-1, GSH and
Trx/TrxR/NAPDH for 30min, and then EMSA were performed with
NF-kB probe. (B) The p50 (0.05mM) was incubated with 0.5mM
APE1/Ref-1 WT or C/S with or without GSH for various times, and
the redox state of p50 was visualized using F5M, as described in
Materials and methods section. Fluorescence intensities of p50 were
measured and plotted against time as fold change from the intensity
of p50 incubated with GSH alone for 30min. Plotted data are means ±
SD from three independent experiments. (C) The p50 WT or C62S
(0.05mM) was incubated with 0.5mM APE1/Ref-1 with or without
GSH for 30min, and then ﬂuorescence assays were performed as in
(B). (D) The p50 (0.05mM) was incubated with the indicated concen-
trations of APE1/Ref-1 with or without Trx/TrxR/NAPDH for 30min,
and then ﬂuorescence assays were performed as in (B).
Nucleic Acids Research, 2008, Vol. 36, No. 13 4331been attributed to its redox activity (20,23,34). As APE1/
Ref-1C/S did not promote p50 DNA binding appreciably
even at the highest concentration used (Figure 1C), it is
likely that APE1/Ref-1C/S is deﬁcient in redox activity.
Besides, it is highly unlikely that a protein with no cysteine
residue exerts redox activity.
APE1/Ref-1 also has DNA-binding activity (41). When
APE1/Ref-1 WT is used in EMSA at high concentrations,
a faster-migrating band is often detected (Figures 1A and
3D; indicated by asterisk). We examined the identity of
this complex by using anti-APE1/Ref-1 and control anti-
bodies and found that anti-APE1/Ref1 antibody selec-
tively abolishes the formation of the faster-migrating
complex (Figure 1A). Hence, this complex is most likely
the APE1/Ref-1-DNA complex. APE1/Ref-1C/S did not
produce such a faster-migrating complex even at the
Figure 3. APE1/Ref-1 enhances DNA-binding activity of p52 and c-Rel,
but not of p65. (A) APE1/Ref-1 physically interacts with p52 and c-Rel,
but not with p65. GST pull-down assays were performed as described in
Materials and methods section. (B–D) p52 (B), c-Rel (C) or p65 (D) was
incubated with 0.5mM APE1/Ref-1 WT or C/S, or control BSA together
with the indicated concentrations of GSH for 30min, and EMSA were
performed with NF-kB probe. Asterisk indicates the APE1/Ref-1–
DNAcomplex.
Figure 4. APE1/Ref-1 enhances DNA-binding activity of AP-1 inde-
pendently of the cysteine residues of APE1/Ref-1. (A) APE1/Ref-1
physically interacts with the c-Jun bZIP, but not with the c-Fos
bZIP. GST pull-down assays were performed as described in
Materials and methods section. (B) APE1/Ref-1 WT or C/S enhances
AP-1 DNA binding in the presence of GSH. A mixture (0.1mM each)
of the c-Jun bZIP and the c-Fos bZIP was incubated with 0.5mM
APE1/Ref-1 WT or C/S, or control BSA (lanes 4 and 8) with or with-
out GSH for 30min, and then EMSA were performed with AP-1
probe. (C) APE1/Ref-1 promotes GSH-mediated reduction of AP-1.
A mixture (0.1mM each) of the c-Jun bZIP and the c-Fos bZIP was
incubated with 0.5mM of APE1/Ref-1 WT or APE1/Ref-1C/S, or con-
trol BSA with or without GSH for the indicated times, and the redox
status of the bZIP proteins was visualized.
4332 Nucleic Acids Research, 2008, Vol. 36, No. 13highest concentrations examined (Figures 1C and 3D),
indicating that APE1/Ref-1C/S is deﬁcient in DNA
binding.
Next, AP endonuclease activity of APE1/Ref-1 was
examined using supercoiled plasmid DNA containing AP
sites as substrate. APE1/Ref-1 is known to cleave the phos-
phodiester bond immediately 50 to AP sites and to create
nicks on damaged DNA. As reported previously (7),
APE1/Ref-1 WT converted the supercoiled DNA substrate
to a relaxed form in a concentration-dependent manner
(Figure 5). In contrast, APE1/Ref-1C/S showed 10000-
fold less activity than APE1/Ref-1 WT (Figure 5). Col-
lectively, APE1/Ref-1C/S possesses redox chaperone
activity comparable to that of wild-type (WT), but lacks
redoxactivity,DNA-binding activityandAPendonuclease
activity. These ﬁndings indicate that redox activity, DNA-
binding activity and AP endonuclease activity of APE1/
Ref-1 are dispensable for its redox chaperone activity.
APE1/Ref-1 activates NF-iB-mediated transcription
independently ofits cysteine residues
A number of previous studies have implicated APE1/Ref-1
in the activation of NF-kB-mediated transcription in living
cells (42,43). To investigate whether redox chaperone activ-
ity of APE1/Ref-1 is involved in the regulation of NF-kBi n
cells, we knocked down APE1/Ref-1 expression in human
293T cells using siRNA. Western blot analysis showed that
the siRNA reduced the APE1/Ref-1 protein level by >90%
2–4daysaftertransfection,whereasithadlittleeﬀectonthe
protein levels of actin and Trx (Figure 6A and C). During
this period, no morphological or growth defects were
observed in APE1/Ref-1-downregulated cells (data not
shown). Then, we examined transcriptional activity of
NF-kB using a reporter gene containing four NF-kB-bind-
ing sites. Transfection of Flag-tagged APE1/Ref-1 WT or
C/S construct resulted in their expression at a level similar
to that of endogenous APE/Ref-1 (Figure 6C) and also
resulted in a 2-fold increase of TNF-a-induced expression
of the reporter gene (Figure 6B). On the other hand, APE1/
Ref-1 knockdown signiﬁcantly attenuated TNF-a-induced
expression of the reporter gene, and transfection of RNAi-
resistant Flag-APE1/Ref-1 WT or C/S into APE1/Ref-1-
downregulated cells restored TNF-a response to a control
level (Figure 6B). TNF-a-induced activation of NF-kB was
then directly measured by carrying out EMSA using
nuclear extracts prepared from the transfected cells. We
found that nuclear DNA-binding activity of NF-kBi s
correlated well with reporter gene activity; i.e. DNA bind-
ing was signiﬁcantly upregulated by expression of Flag-
APE1/Ref-1 and downregulated by APE1/Ref-1 siRNA,
and there was no appreciable functional diﬀerence between
APE1/Ref-1 WT and C/S (Figure 6D). These results
demonstrate that APE1/Ref-1 activates NF-kB-mediated
Figure 5. APE1/Ref-1C/S lacks AP endonuclease activity. AP endonu-
clease activity of APE1/Ref-1 was examined by the conversion of super-
coiled, depurinated pBluescript II SK(+) to a nicked form.
Depurinated DNA (200ng) in a 20ml reaction volume was incubated
with the indicated concentrations of APE1/Ref-1 for 15min at 378C,
electrophoresed on a 0.8% agarose gel and visualized by ethidium
bromide staining.
Figure 6. APE1/Ref-1 activatesNF-kB-dependent transcriptionindepen-
dently of its cysteine residues in living cells. (A) siRNA-mediated knock-
down of APE1/Ref-1. The 293T cells were transfected with siRNA for
APE1/Ref-1 or control GFP and various days later, harvested for immu-
noblot analysis. (B–D) The 293T cells were transfected with various com-
binations of siRNA, NF-kB-driven and control reporter plasmids, and
siRNA-resistant APE1/Ref-1 expression plasmids. Where indicated,
TNF-a was added 24h before harvest. Cell lysates were subjected to luci-
ferase assays (B), immunoblotting (C) and EMSA (D). Asterisk in (D)
indicates a nonspeciﬁc band. Results in (B) are means ±SD from three
independent experiments.
 P<0.01, unpaired t-test.
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bly through its redox chaperone activity in living cells.
DISCUSSION
A number of previous reports have demonstrated that
APE1/Ref-1 activates DNA-binding activity of many
redox-sensitive transcription factors by directly reducing
their cysteine residues (6–17,20,23,34). In the present
study, we discovered novel activity of APE1/Ref-1 termed
redox chaperone activity, by which APE1/Ref-1 regulates
DNA-binding activity of various transcription factors
through promoting reduction of their critical cysteine resi-
dues by other reducing molecules such as GSH and Trx.
Redox chaperone activity seems to be mediated by direct
interactions between APE1/Ref-1 and target transcription
factors, and does not require high concentrations of APE1/
Ref-1 as its redox activity. From previous quantitative
immunoblot analysis (23), the concentration of APE1/
Ref-1 in the cell nucleus is estimated to be >1mM, which
is comparable to the concentrations needed to observe
redox chaperone activity in vitro (Figures 1–4). On the
other hand, intracellular concentrations of GSH and Trx
are estimated to be around 1mM and 1mM, respectively
(44), which are also comparable to the concentrations used
in this study. It is therefore plausible that APE1/Ref-1 reg-
ulates redox-sensitive transcription factors through redox
chaperone activity in living cells.
APE1/Ref-1 is, to our knowledge, the ﬁrst example of a
redox chaperone, and hence, this study adds a new dimen-
sion in our understanding of cellular redox regulation.
Here, we propose three possible mechanisms for redox cha-
perone activity of APE1/Ref-1. First, APE1/Ref-1 may
facilitate reduction of target transcription factors by bridg-
ing between the target transcription factors and reducing
molecules such as GSH and Trx (recruitment model).
Second, APE1/Ref-1 may facilitate reduction by inducing
conformational change of target transcription factors such
that redox-sensitive cysteine residues become more acces-
sible to reducing molecules (conformational change
model). Third, APE1/Ref-1 may stabilize the reduced
states of target transcription factors by preventing oxida-
tion of redox-sensitive cysteine residues, possibly through
hydrogen bond formation with the thiol groups (oxidation
barriermodel). Thesemodels arenotmutually exclusive. In
support of the ﬁrst model, it has been shown that APE1/
Ref-1 physically interacts with Trx (45–47). However, the
ﬁnding that APE1/Ref-1 facilitates reduction by structu-
rally unrelated reducing molecules such as GSH and Trx
may suggest that the speciﬁcity of redox reactions is deter-
mined solely by APE1/Ref-1, and that the type of reducing
molecules is not important, the idea that is consistent with
the second and third models.
Although redox activity of APE1/Ref-1 was found to be
dispensable for its redox chaperone activity, we still think
that these activities are mechanistically similar. This idea
is more plausible than the idea that the two functionally
related activities embedded in the single protein are
exerted by distinct mechanisms. In our scenario, APE1/
Ref-1 binding to target transcription factors enhances
their ability to be reduced, and then reduction is carried
out by other reducing molecules or APE1/Ref-1 itself;
APE1/Ref-1 is regarded as a redox chaperone in the
former case and as a redox factor in the latter case.
We showed that APE1/Ref-1C/S possesses redox cha-
perone activity, but lacks redox activity, AP endonuclease
activityandDNA-bindingactivity.Fromtheseﬁndings,we
discuss structure–function relationships of APE1/Ref-1.
X-ray crystallography suggests that the seven cysteine resi-
dues of APE1/Ref-1 neither form any disulﬁde bond nor
are integral to the tertiary structure (37). It is therefore
plausible that the tertiary structure of APE1/Ref-1C/S is
similar to that of WT. For redox activity of APE1/Ref-1,
the N-terminal region spanning amino acids 1–127 is
shown to be necessary and suﬃcient for this activity (48).
Here,weprovidedevidencethatmutationofallthecysteine
residues abolishes redox activity, the ﬁnding that is theo-
retically reasonable. Thus, Cys-65, Cys-93 and Cys-99, the
three cysteine residues within the N-terminal region, may
be responsible for redox activity. As for AP endonuclease
activity, it has been shown that mutation of each of the
seven cysteine residues has no discernable eﬀect on this
activity (49). Therefore, combined mutations of two or
more cysteine residues are likely responsible for the defec-
tive AP endonuclease activity of APE1/Ref-1C/S.
APE1/Ref-1 null mice are unable to develop beyond
the point of implantation, underscoring its vital role
in vivo (50). Others reported that moderate downregula-
tion of APE1/Ref-1 with antisense cDNA in human cells
increases sensitivity to oxidative stress and attenuates
NF-kB activation (51). More recently, it was shown that
potent downregulation of APE1/Ref-1 with siRNA arrests
cell proliferation and causes apoptosis with accumulation
of abasic DNA damage in several human cell lines (52).
On the other hand, APE1/Ref-1 expression is induced by
reactive oxygen species, such as the superoxide anion
H2O2 and the hydroxyl radical (
 OH) (53–56). Thus,
APE1/Ref-1 plays a critical role in an antioxidative
stress response pathway leading to activation of several
transcription factors.
It remains elusive exactly how APE1/Ref-1 carries out
its essential functions in vivo. Fung and Demple (52)
showed that defects associated with APE1/Ref-1 down-
regulation in human cells, such as accumulation of DNA
damage and apoptotic cell death, are largely rescued by
ectopic expression of yeast Apn1, an AP endonuclease
that shows little structural homology to APE1/Ref-1 and
is thus thought to have no other APE1/Ref-1 activities. In
contrast, we showed here that the attenuation of NF-kB-
dependent reporter gene expression, triggered by APE1/
Ref-1 downregulation in human cells, is reversed by over-
expression of Ref1C/S, the mutant that possesses redox
chaperone activity but are defective in redox activity,
DNA-binding activity and AP endonuclease activity.
Thus, APE1/Ref-1 may play multiple roles in the antiox-
idative stress response pathway in vivo through its diﬀerent
biochemical activities.
In conclusion, we discovered a novel biochemical activ-
ity of APE1/Ref-1 termed redox chaperone activity that
regulates DNA-binding activities of various transcription
factors through promoting the reduction of their critical
4334 Nucleic Acids Research, 2008, Vol. 36, No. 13cysteine residues by other reducing molecules such as
GSH and Trx. This ﬁnding provides new insight into the
mechanism of cellular redox regulation. The physiological
signiﬁcance of this ﬁnding awaits further investigation.
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